4 ms·
preprint is available here. its a better view of the particulars https://www.biorxiv.org/content/10.1101/2020.08.25.265561v1 https://www.biorxiv.org/content/10
by rolph 6y ago
preprint is available here. its a better view of the particulars
https://www.biorxiv.org/content/10.1101/2020.08.25.265561v1 https://www.biorxiv.org/content/10.1101/2020.08.25.265561v1
bioRxiv preprint doi: https://doi.org/10.1101/2020.08.25.265561 https://doi.org/10.1101/2020.08.25.265561 . this version posted August 25, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder. It is made available under a CC-BY-ND 4.0 International license .
also:: Competing Interest Statement
>> B.R.C. is a founder of Tenaya Therapeutics (https://www.tenayatherapeutics.com/ https://www.tenayatherapeutics.com/), a company focused on finding treatments for heart failure, including genetic cardiomyopathies. B.R.C. and T.C.M. hold equity in Tenaya. <<